Assessment of the Dexmedetomidin effect on postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy
Phase 1
- Conditions
- Patients undergoing laparoscopic cholecystectomy.
- Registration Number
- IRCT20170411033365N2
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Adult Patients with Physical Status I-II of the American Society of Anesthesiologists (ASA) undergoing laparoscopic cholecystectomy for acute and chronic cholecystitis
Exclusion Criteria
Sensitivity to drugs in the study, receiving antiemetic drugs in the last 48 hours before surgery and body mass index above 35 kg / m2, surgery more than 2 hours, other concomitant surgery, complications during or after surgery and dissatisfaction with the company in this study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea / vomiting. Timepoint: recovery. Method of measurement: A score of zero was equivalent to no nausea or vomiting and a score of 5 was equivalent to the highest severity of nausea or vomiting.
- Secondary Outcome Measures
Name Time Method